{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:41:55Z","timestamp":1791204115766,"version":"4.2.0"},"reference-count":28,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The relationship between anti-M\u00fcllerian hormone (AMH) levels and body weight, expressed through body mass index (BMI), in women with PCOS has been a topic of discussion for a long time, yet the literature continues to present conflicting data. The latest guidelines emphasize the growing role of AMH in the diagnosis of polycystic ovary syndrome and suggest that it should become one of the diagnostic criteria for identifying this condition. Objectives: The aim of this study was to determine the relationship between AMH levels and BMI in reproductive-age patients. The bioethics committee approved the conduct of the study. Methods: A total of 193 patients diagnosed with polycystic ovary syndrome (PCOS) based on the Rotterdam criteria were included in the study group. The control group consisted of 196 patients who did not meet the diagnostic criteria for PCOS. Blood samples (5 mL of venous blood) were collected from all participants to determine AMH levels. Additionally, body weight and height were measured, and BMI was calculated. Results: The mean AMH level for women with PCOS was 7.187 ng\/mL (median: 6.400 ng\/mL) and was more than twice as high as women without PCOS (mean: 3.399 ng\/mL, median: 2.835 ng\/mL). The decline in the average AMH level occurs at an older age (35\u201339 years) in women with PCOS compared to women without PCOS (25\u201329 years). A significant negative correlation between AMH levels and BMI was observed only in women with PCOS in the 25\u201329 age group. In women in the 20\u201324 age group, this correlation takes the form of a statistical tendency. Conclusions: Obesity is a modifiable factor influencing AMH levels. The demonstrated relationship between AMH and BMI may contribute to the development of therapeutic protocols tailored to the patient\u2019s clinical condition.<\/jats:p>","DOI":"10.3390\/jcm14082677","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T07:42:01Z","timestamp":1744616521000},"page":"2677","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of Anti-M\u00fcllerian Hormone (AMH) Serum Levels in Patients with Polycystic Ovary Syndrome (PCOS) Depending on Body Mass Index (BMI)"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7632-1298","authenticated-orcid":false,"given":"Amalia","family":"Gorzko","sequence":"first","affiliation":[{"name":"Individual Medical Practice, 71-276 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5421-0339","authenticated-orcid":false,"given":"Mariia","family":"Melnyk","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Endocrinology and Gynecological Oncology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Nawrocka-Rutkowska","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Endocrinology and Gynecological Oncology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Starczewski","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Endocrinology and Gynecological Oncology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Marciniak","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Endocrinology and Gynecological Oncology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1518-8838","authenticated-orcid":false,"given":"Iwona","family":"Szyd\u0142owska","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Endocrinology and Gynecological Oncology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Singh, S., Pal, N., Shubham, S., Sarma, D.K., Verma, V., Marotta, F., and Kumar, M. (2023). Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics. J. Clin. Med., 12.","DOI":"10.3390\/jcm12041454"},{"key":"ref_3","first-page":"263349412091103","article-title":"Characteristics of polycystic ovary syndrome throughout life","volume":"14","author":"Louwers","year":"2020","journal-title":"Ther. Adv. Reprod. Health"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e210243","DOI":"10.1530\/EC-21-0243","article-title":"Anti-M\u00fcllerian hormone was independently associated with central obesity but not with general obesity in women with PCOS","volume":"11","author":"Zeng","year":"2022","journal-title":"Endocr. Connect."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Sivanandy, M.S., and Ha, S.K. (2023). The Role of Serum Anti-Mullerian Hormone Measurement in the Diagnosis of Polycystic Ovary Syndrome. Diagnostics, 13.","DOI":"10.3390\/diagnostics13050907"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Rudnicka, E., Kunicki, M., Calik-Ksepka, A., Suchta, K., Duszewska, A., Smolarczyk, K., and Smolarczyk, R. (2021). Anti-M\u00fcllerian Hormone in Pathogenesis, Diagnostic and Treatment of PCOS. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222212507"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"515.e1","DOI":"10.1016\/j.ajog.2021.06.052","article-title":"Anti-M\u00fcllerian hormone levels among contraceptive users: Evidence from a cross-sectional cohort of 27,125 individuals","volume":"225","author":"Hariton","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Iwase, A., Hasegawa, Y., Tsukui, Y., Kobayashi, M., Hiraishi, H., Nakazato, T., and Kitahara, Y. (2023). Anti-M\u00fcllerian hormone beyond an ovarian reserve marker: The relationship with the physiology and pathology in the life-long follicle development. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1273966"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kotlyar, A.M., and Seifer, D.B. (2021). Ethnicity\/Race and Age-Specific Variations of Serum AMH in Women-A Review. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.593216"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/j.fertnstert.2019.08.088","article-title":"Reprint of: Antim\u00fcllerian hormone serum levels: A putative marker for ovarian aging","volume":"112","author":"Laven","year":"2019","journal-title":"Fertil. Steril."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Oldfield, A.L., Kazemi, M., and Lujan, M.E. (2021). Impact of Obesity on Anti-Mullerian Hormone (AMH) Levels in Women of Reproductive Age. J. Clin. Med., 10.","DOI":"10.3390\/jcm10143192"},{"key":"ref_12","unstructured":"B\u0105k-Sosnowska, M., Bia\u0142kowska, M., Bogda\u0144ski, P., and Chomiuk, T. (2022). Zalecenia kliniczne dotycz\u0105ce post\u0119powania u chorych na oty\u0142o\u015b\u0107 2022\u2014Stanowisko Polskiego Towarzystwa Leczenia Oty\u0142o\u015bci. Med. Prakt. Wyd. Specj., 1\u201387."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/humrep\/dead053","article-title":"Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: A Mendelian randomization study with meta-analysis","volume":"38","author":"Dobbie","year":"2023","journal-title":"Hum. Reprod."},{"key":"ref_14","unstructured":"Weir, C.B., and Jan, A. (2024, November 01). BMI Classification Percentile and Cut Off Points, StatPearls, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK541070\/."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Hyldgaard, J., Bor, P., Ingerslev, H.J., and T\u00f8rring, N. (2015). Comparison of two different methods for measuring anti-mullerian hormone in a clinical series. Reprod. Biol. Endocrinol., 13.","DOI":"10.1186\/s12958-015-0101-5"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Kelsey, T.W., Wright, P., Nelson, S.M., Anderson, R.A., and Wallace, W.H. (2011). A validated model of serum anti-m\u00fcllerian hormone from conception to menopause. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0022024"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Butt, M.S., Saleem, J., Aiman, S., Zakar, R., Sadique, I., and Fischer, F. (2022). Serum anti-M\u00fcllerian hormone as a predictor of polycystic ovarian syndrome among women of reproductive age. BMC Womens Health, 22.","DOI":"10.1186\/s12905-022-01782-2"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"103628","DOI":"10.1016\/j.jri.2022.103628","article-title":"Systemic and ovarian inflammation in women with polycystic ovary syndrome","volume":"151","author":"Zhai","year":"2022","journal-title":"J. Reprod. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9511772","DOI":"10.1155\/2021\/9511772","article-title":"AMH Is a Good Predictor of Metabolic Risk in Women with PCOS: A Cross-Sectional Study","volume":"2021","author":"Ou","year":"2021","journal-title":"Int. J. Endocrinol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/IJWH.S393594","article-title":"The Relationship Between Insulin Resistance and Obesity and Serum Anti-Mullerian Hormone Level in Chinese Women with Polycystic Ovary Syndrome: A Retrospective, Single-Center Cohort Study","volume":"15","author":"Zhao","year":"2023","journal-title":"Int. J. Womens Health"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e12638","DOI":"10.1111\/cob.12638","article-title":"Increased body mass index is negatively associated with ovarian reserve as measured by anti-M\u00fcllerian hormone in patients with polycystic ovarian syndrome","volume":"14","author":"Kloos","year":"2024","journal-title":"Clin. Obes."},{"key":"ref_22","first-page":"179","article-title":"Impact of body mass index and vitamin D on serum AMH levels and antral follicle count in PCOS","volume":"27","author":"Celik","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s12020-021-02839-2","article-title":"Association of body mass index with serum anti-M\u00fcllerian hormone and inhibin B levels among 8323 women attending a reproductive medical center: A cross-sectional study","volume":"75","author":"Wang","year":"2022","journal-title":"Endocrine"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3390\/reprodmed4030018","article-title":"Relationship between Ovarian Reserve Markers and Body Mass Index in Infertile Women with and without Polycystic Ovary Syndrome: A Retrospective Case\u2013Control Study","volume":"4","author":"Casadei","year":"2023","journal-title":"Reprod. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/a-0650-4723","article-title":"Obesity Does not Compromise Ovarian Reserve Markers in Infertile Women","volume":"79","author":"Gorkem","year":"2019","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Gouvea, T.M., Cota, E., Souza, L.A., and Lima, A.A. (2022). Correlation of serum anti-Mullerian hormone with hormonal and environmental parameters in Brazilian climacteric women. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-15429-7"},{"key":"ref_27","first-page":"e16047","article-title":"Correlation of Homeostatic Model Assessment-Insulin Resistance, Anti-Mullerian Hormone, and BMI in the Characterization of Polycystic Ovary Syndrome","volume":"13","author":"Bahadur","year":"2021","journal-title":"Cureus"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Meneghini, C., Bianco, C., Galanti, F., Tamburelli, V., Dal Lago, A., Licata, E., Gallo, M., Fabiani, C., Corno, R., and Miriello, D. (2023). The Impact of Nutritional Therapy in the Management of Overweight\/Obese PCOS Patient Candidates for IVF. Nutrients, 15.","DOI":"10.3390\/nu15204444"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/8\/2677\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:14:12Z","timestamp":1760030052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/8\/2677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":28,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["jcm14082677"],"URL":"https:\/\/doi.org\/10.3390\/jcm14082677","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]}}}